Approval · Notice of Compliance 3341 · 1997
TEGRETOL: Notice of Compliance 3341
Issued May 29, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3341
- Date
- May 29, 1997
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anticonvulsant, Symptomatic Relief of Trigenal Neuragia, Antimanic
Products in this notice
Medicinal ingredients
- CARBAMAZEPINE 200 MG per TAB
- CARBAMAZEPINE 100 MG per TAB
- CARBAMAZEPINE 400 MG per TAB
- CARBAMAZEPINE 100 MG per 5ML